Creso Financial Statements From 2010 to 2025
| COPHFDelisted Stock | USD 0.12 0.00 0.00% |
Check Creso Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creso Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Creso financial statements analysis is a perfect complement when working with Creso Pharma Valuation or Volatility modules.
Creso |
Creso Pharma Limited Company Operating Margin Analysis
Creso Pharma's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Creso Pharma Operating Margin | (2.39) % |
Most of Creso Pharma's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Creso Pharma Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Creso Pharma Limited has an Operating Margin of -2.3867%. This is 93.2% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 56.68% lower than that of the firm.
Creso Pharma Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Creso Pharma's current stock value. Our valuation model uses many indicators to compare Creso Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Creso Pharma competition to find correlations between indicators driving Creso Pharma's intrinsic value. More Info.Creso Pharma Limited is number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Creso Pharma's earnings, one of the primary drivers of an investment's value.About Creso Pharma Financial Statements
Creso Pharma stakeholders use historical fundamental indicators, such as Creso Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Creso Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Creso Pharma's assets and liabilities are reflected in the revenues and expenses on Creso Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Creso Pharma Limited. Please read more on our technical analysis and fundamental analysis pages.
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Creso Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Creso Pink Sheet
If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |